ANL · Adlai Nortye Group Ltd ADR
United States · RS rating 30 · As of 2026-11-03
| Price | 9.58 USD |
|---|---|
| 1-day change | +2.2% |
| RS rating (overall / 1M / 3M / 12M) | 30 / 8 / 24 / 99 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 31 / 33 / 16 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +42.3% |
| Market cap (USD) | $791.4M |